What KORU Medical Systems Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 8 |
| Sells | 0 | 0 |
| Total trades | 7 | 53 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 65,274 | 1,387,228 |
| Disposed | 0 | 1,625,104 |
| Net activity | +65,274 | −237,876 |
Common stock only — 1 reported trade in the last 12 months is in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Fletcher R John | Director | Oct 01 | Grant / award · A | +7,679 | $2.93 | +$22.5K | 239,836 |
| Matin Shahriar | Director | Oct 01 | Grant / award · A | +5,119 | $2.93 | +$15K | 106,263 |
| Wholihan Edward | Director | Oct 01 | Grant / award · A | +5,119 | $2.93 | +$15K | 56,431 |
| Cascella Robert | Director | Oct 01 | Grant / award · A | +5,119 | $2.93 | +$15K | 103,274 |
| French Donna | Director | Oct 01 | Grant / award · A | +5,119 | $2.93 | +$15K | 103,633 |
| Manko Joseph M. Jr. | Director | Sep 30 | Grant / award · A | +5,119 | — | — | 5,074,660 |
| Kalbermatten Adam R | Chief Commercial Officer | Sep 08 | Open-market buy · P | +32,000 | $3.16 | +$101K | 394,017 |
| Kalbermatten Adam R | Chief Commercial Officer | Jul 28 | Withheld — tax / exercise cost · F | −25,483 | $4.26 | −$109K | 362,017 |
| Kalbermatten Adam R | Chief Commercial Officer | Jul 28 | Exercise / conversion · M | +75,000 | — | — | 387,500 |
| Cascella Robert | Director | Jul 01 | Grant / award · A | +3,571 | $4.20 | +$15K | 98,155 |
| Fletcher R John | Director | Jul 01 | Grant / award · A | +5,357 | $4.20 | +$22.5K | 232,157 |
| French Donna | Director | Jul 01 | Grant / award · A | +3,571 | $4.20 | +$15K | 98,514 |
| Matin Shahriar | Director | Jul 01 | Grant / award · A | +3,571 | $4.20 | +$15K | 101,144 |
| Wholihan Edward | Director | Jul 01 | Grant / award · A | +3,571 | $4.20 | +$15K | 51,312 |
| Manko Joseph M. Jr. | Director | Jun 30 | Grant / award · A | +3,571 | — | — | 5,069,541 |
| Kalbermatten Adam R | President-Chief Commercial Off | Jun 11 | Open-market buy · P | +7,500 | $3.93 | +$29.5K | 312,500 |
| Kalbermatten Adam R | President-Chief Commercial Off | Jun 11 | Open-market buy · P | +5,000 | $3.96 | +$19.8K | 305,000 |
| Schiller Eric | Chief Technology Officer | May 18 | Open-market buy · P | +5,000 | $3.91 | +$19.6K | 5,000 |
| Tharby Linda M | Chief Executive Officer | May 15 | Open-market buy · P | +1,191 | $3.92 | +$4.67K | 620,622 |
| Tharby Linda M | Chief Executive Officer | May 14 | Withheld — tax / exercise cost · F | −7,326 | $3.94 | −$28.9K | 619,431 |
Loading...
